YORK JEREMY SCHULENBURG,WALLACE OWEN BRENDAN,XU YANPING
申请号：
SI200730872
公开号：
SI2049513T1
申请日:
2007.04.27
申请国别(地区):
SI
年份:
2012
代理人:
摘要：
The present invention discloses novel compounds of Formula I: having 11&bgr-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11&bgr-HSD type 1 activity.
